REQUEST A DEMO
Total
USD $0.00
Search more companies

Wai Yuen Tong Medicine Holdings Limited (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Wai Yuen Tong Medicine Holdings Limited Profile Updated: September 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Principal activities comprise the production and sale of traditional Chinese and Western pharmaceutical products, health foods products and property holding and properties investment.

Headquarters
Suite 3101, 31/F., Skyline Tower, 39 Wang Kwong Road, Kowloon Bay
Hong Kong; Hong Kong;

Contact Details: Purchase the Wai Yuen Tong Medicine Holdings Limited report to view the information.

Website: http://www.wyth.net

Basic Information
Total Employees:
Purchase the Wai Yuen Tong Medicine Holdings Limited report to view the information.
Outstanding Shares:
Purchase the Wai Yuen Tong Medicine Holdings Limited report to view the information.
Registered Capital:
Purchase the Wai Yuen Tong Medicine Holdings Limited report to view the information.
Financial Auditors:
Purchase the Wai Yuen Tong Medicine Holdings Limited report to view the information.
Incorporation Date:
August 12, 1994
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Total Smart Investment Ltd (United Kingdom)
100%
Asia Brighter Investment Limited
Billion Good Investment Limited
Company Performance
Financial values in the chart are available after Wai Yuen Tong Medicine Holdings Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HKD. Absolute financial data is included in the purchased report.
Net sales revenue
4%
Total operating revenue
16.98%
Operating profit (EBIT)
101.59%
EBITDA
50.27%
Net Profit (Loss) for the Period
20.85%
Total assets
-70.13%
Total equity
-62.44%
Operating Profit Margin (ROS)
6.75%
Net Profit Margin
0.04%
Return on Equity (ROE)
0.2%
Debt to Equity Ratio
-3.9%
Quick Ratio
0.73%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?